Thanks TheWetDog.I missed these.For ease of reading, and so...

Thanks TheWetDog.

I missed these.

For ease of reading, and so everyone has the opportunity to see CDX responses here on HC, I've put them all together.

1/5:We now have the strongest balance sheet in over 5-years with record 5-year cash reserves. Adding to this is the strongest pharma revenues the company has had in over 5-years.

2/5: New patents recently announced put an impenetrable fence around our proprietary technology in cardiovascular health.

3/5: Multiple global deals recently announced deliver on our new device strategy. World-first (patent-pending) wearable sensor technology for heart health also announced in April this year.

4/5: Stock price the last few days reflects a "standard" ASX inquiry which they ask of all companies that have a qualified audit irrespective of the materiality of the qualification.

5/5: Our qualification being as to the classification of certain convertible notes and is completely and categorically unrelated to the ongoing operating, cash flow, strategic, business, and financial position of the company which is the strongest it has ever been.

5/5+: Certain ASX enquires were completely irrelevant to us, and irresponsible to ask - and we forcefully stated so to the ASX.

5/5++: ASX should never be allowed to influence market perceptions by posing unsubstantiated questions that are recklessly driven towards creating unwarranted uncertainty.

5/5+++:We are stronger than ever before, with more cash, higher revenues, more opportunities, and are executing precisely on our growth and product plan as promised to shareholders. Let there be no doubt about this.